If you’re looking for a natural and effective alternative to prescription adderall medication, this guide is for you.
The drug, lecanemab, was approved by the FDA this summer. The UW study focuses on patients without symptoms who have early ...
Just four months after the Food and Drug Administration gave full approval to a new Alzheimer’s drug, it’s estimated that ...
“This confirmatory study verified that it is a safe and effective treatment for patients with Alzheimer’s disease," said FDA's neurology drug director, Dr. Teresa Buracchio, in a statemen ...
The trial is designed to analyse the safety and efficacy of 30mg and 60mg doses of ACP-204 versus those of placebo.
The drug, LOY-001 is designed to address the shorter lifespans of larger breeds and is anticipated to hit the market in 2026.
A medication that could help treat early stages of Alzheimer's disease is on track to be approved for manufacturing and sales in Japan after being endorsed by a health ministry expert panel on ...
On Saturday, Anavex presented interim results from a small clinical trial of its drug Anavex 2-73 at an Alzheimer's research meeting in Barcelona. The Anavex data presentation didn't even come ...
Nov. 29, 2023 — Investigators revealed how genetic changes in certain types of brain cells may contribute to the inflammatory response seen in Alzheimer's ... Brain Boost: Can a Coach Help ...
Excessive television-watching is tied to an increased risk for dementia, PD, and depression, whereas a limited amount of nonwork-related computer use is linked to a lower dementia risk.
The two developments come after the U.S. Food and Drug Administration approved a controversial Alzheimer’s drug called Aduhelm last week. The agency approved the drug despite an advisory committee’s ...
The FDA approved brexpiprazole, sold by Otsuka and Lundbeck as Rexulti, for treating dementia-related agitation caused by Alzheimer’s disease. Through fundraising, theater, and becoming a ...
